4.08
price up icon6.53%   0.25
after-market Dopo l'orario di chiusura: 4.05 -0.03 -0.74%
loading

Esperion Therapeutics Inc Borsa (ESPR) Ultime notizie

pulisher
Dec 09, 2025

Why The Narrative Around Esperion Therapeutics Is Shifting After Analyst Upgrades And Trial Results - Yahoo Finance

Dec 09, 2025
pulisher
Dec 09, 2025

Esperion announces inducement grants under Nasdaq Listing Rule - marketscreener.com

Dec 09, 2025
pulisher
Dec 09, 2025

Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - The Manila Times

Dec 09, 2025
pulisher
Dec 09, 2025

Esperion Grants Stock Options and RSUs to New Chief Commercial Officer and Employees - Quiver Quantitative

Dec 09, 2025
pulisher
Dec 09, 2025

Esperion (NASDAQ: ESPR) awards 380K options, 435,536 RSUs in inducement grants - Stock Titan

Dec 09, 2025
pulisher
Dec 07, 2025

Is Esperion Therapeutics Inc a good long term investmentMarket Sentiment Indicators & High Profit Market Tips - earlytimes.in

Dec 07, 2025
pulisher
Dec 06, 2025

Esperion Therapeutics Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis

Dec 06, 2025
pulisher
Dec 05, 2025

Two Seas Capital LP Raises Holdings in Esperion Therapeutics, Inc. $ESPR - MarketBeat

Dec 05, 2025
pulisher
Dec 05, 2025

Will Esperion Therapeutics Inc. (0ET) stock enhance shareholder valueEarnings Overview Summary & Smart Money Movement Alerts - Newser

Dec 05, 2025
pulisher
Dec 04, 2025

Esperion stock hits fair value target with 77% gain since April 2024 - Investing.com Australia

Dec 04, 2025
pulisher
Dec 03, 2025

Esperion Therapeutics, Inc.Common Stock (Nasdaq:ESPR) Stock Quote - Markets Financial Content

Dec 03, 2025
pulisher
Dec 03, 2025

Esperion Therapeutics, Inc. (NASDAQ:ESPR) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Dec 03, 2025
pulisher
Dec 03, 2025

Is Esperion Therapeutics Inc. (0ET) stock a top dividend aristocrat candidateTrend Reversal & Stepwise Trade Execution Plans - Newser

Dec 03, 2025
pulisher
Nov 28, 2025

Esperion Therapeutics (NASDAQ:ESPR) Hits New 52-Week HighShould You Buy? - MarketBeat

Nov 28, 2025
pulisher
Nov 27, 2025

Esperion Therapeutics (NASDAQ:ESPR) Trading 6% HigherHere's What Happened - MarketBeat

Nov 27, 2025
pulisher
Nov 27, 2025

Esperion a new overweight at Piper Sandler on CV franchise - MSN

Nov 27, 2025
pulisher
Nov 26, 2025

Traders Purchase Large Volume of Call Options on Esperion Therapeutics (NASDAQ:ESPR) - MarketBeat

Nov 26, 2025
pulisher
Nov 26, 2025

Esperion Therapeutics (NASDAQ:ESPR) Coverage Initiated at Piper Sandler - MarketBeat

Nov 26, 2025
pulisher
Nov 25, 2025

Esperion Therapeutics Stock Hits Near 1-Year High As Wall Street Sees Strong Risk-Reward Play On Demand For Cholesterol Drug - Stocktwits

Nov 25, 2025
pulisher
Nov 25, 2025

Esperion Therapeutics: Soaring Momentum Observed - StocksToTrade

Nov 25, 2025
pulisher
Nov 25, 2025

Piper Sandler Initiates Coverage of Esperion Therapeutics (ESPR) with Overweight Recommendation - Nasdaq

Nov 25, 2025
pulisher
Nov 25, 2025

Piper Sandler initiates Esperion Therapeutics stock with Overweight rating By Investing.com - Investing.com South Africa

Nov 25, 2025
pulisher
Nov 25, 2025

Esperion’s Strategic Moves: What It Means? - StocksToTrade

Nov 25, 2025
pulisher
Nov 25, 2025

Esperion Therapeutics Shares Rise After Piper Sandler Initiates Coverage - marketscreener.com

Nov 25, 2025
pulisher
Nov 25, 2025

Esperion Stock Grows Amid Promising Japanese Partnership and Q3 Earnings - timothysykes.com

Nov 25, 2025
pulisher
Nov 25, 2025

Why Analysts Are Rewriting Esperion’s Story After New Pipeline Results and Global Partnerships - Yahoo Finance

Nov 25, 2025
pulisher
Nov 25, 2025

Esperion gains after Piper Sandler initiates with 'overweight' rating - TradingView

Nov 25, 2025
pulisher
Nov 25, 2025

United StatesGoodwin Advises Esperion On $75 Million Underwritten Public Offering - Mondaq

Nov 25, 2025
pulisher
Nov 25, 2025

Piper Sandler initiates Esperion Therapeutics stock with Overweight rating - Investing.com

Nov 25, 2025
pulisher
Nov 21, 2025

Esperion shares rise as Otsuka launches NEXLETOL in Japan By Investing.com - Investing.com Nigeria

Nov 21, 2025
pulisher
Nov 21, 2025

Esperion Therapeutics Partner Rolls Out Nexletol Tablets in Japan to Treat Hypercholesterolemia - MarketScreener

Nov 21, 2025
pulisher
Nov 21, 2025

Esperion stock rises after $90 million payment from Japan launch By Investing.com - Investing.com Australia

Nov 21, 2025
pulisher
Nov 21, 2025

Esperion stock rises after $90 million payment from Japan launch - Investing.com

Nov 21, 2025
pulisher
Nov 21, 2025

Is Esperion Therapeutics Inc. stock undervalued vs historical averages2025 Big Picture & Free Daily Entry Point Trade Alerts - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Esperion shares rise as Otsuka launches NEXLETOL in Japan - Investing.com India

Nov 21, 2025
pulisher
Nov 21, 2025

Esperion partner Otsuka launches Nexletol in Japan - MarketScreener

Nov 21, 2025
pulisher
Nov 21, 2025

Esperion Partners with Otsuka to Launch NEXLETOL in Japan, Secures $90 Million Payment - Quiver Quantitative

Nov 21, 2025
pulisher
Nov 21, 2025

Esperion Partner Otsuka Launches NEXLETOL® in Japan for the Treatment of Hypercholesterolemia - The Manila Times

Nov 21, 2025
pulisher
Nov 20, 2025

Is Esperion Therapeutics Inc. stock a safe investment in uncertain markets2025 Geopolitical Influence & AI Based Buy/Sell Signal Reports - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Will Esperion Therapeutics Inc. stock recover faster than marketTreasury Yields & Daily Profit Focused Screening - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Why retail investors favor Esperion Therapeutics Inc. stock2025 Big Picture & High Conviction Buy Zone Picks - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Esperion: HLS Therapeutics (TSX:HLS) Secures Health Canada Clearance for NILEMDO® - Kalkine Media

Nov 19, 2025
pulisher
Nov 19, 2025

Why Esperion Therapeutics Inc. is moving todayMarket Movement Recap & Expert Verified Movement Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Multi asset correlation models including Esperion Therapeutics Inc.Portfolio Return Summary & Low Drawdown Momentum Ideas - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will Esperion Therapeutics Inc. stock outperform international peersQuarterly Earnings Summary & Stepwise Trade Execution Plans - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Esperion to Participate in Piper Sandler 37th Annual Healthcare Conference - The Manila Times

Nov 19, 2025
pulisher
Nov 19, 2025

Can Esperion Therapeutics Inc. stock double in next 5 yearsJuly 2025 Retail & Safe Swing Trade Setups - newser.com

Nov 19, 2025
$37.77
price down icon 0.26%
$21.27
price down icon 0.02%
drug_manufacturers_specialty_generic RDY
$14.09
price up icon 1.66%
$11.59
price down icon 0.09%
$154.75
price down icon 0.57%
$488.51
price up icon 0.84%
Capitalizzazione:     |  Volume (24 ore):